How does biotherapy interact with the immune system in cancer treatment?

How does biotherapy interact with the immune system in cancer treatment?

• A. It suppresses the immune system to directly target cancer cells
• B. It enhances the immune system's ability to recognize and destroy cancer cells
• C. It replaces the immune system entirely during treatment
• D. It has no significant effect on the immune system

Answer: (B)

Biotherapy, also known as immunotherapy, primarily functions by enhancing the immune system's ability to recognize and effectively destroy cancer cells. It works on the principle that the immune system can be trained or boosted to identify cancer cells as threats, promoting a more vigorous immune response against tumors. Agents used in biotherapy, such as monoclonal antibodies, immune checkpoint inhibitors, and cancer vaccines, play crucial roles in this enhancement. For example, monoclonal antibodies can help the immune system by marking cancer cells for destruction or by blocking the signals that cancers use to evade immune detection. Immune checkpoint inhibitors release the "brakes" on the immune system, allowing T cells to target and kill cancer cells more effectively. By fostering a more robust immune response, biotherapy not only targets cancer cells more efficiently but also holds the potential for lasting effects, as a well-functioning immune system can continue to monitor and potentially prevent cancer recurrence after initial treatment. This interaction with the immune system exemplifies a shift from traditional cancer therapies, which often focus on direct cytotoxic effects, to approaches that utilize the body's own defense mechanisms.

Biotherapy, also known as immunotherapy, primarily functions by enhancing the immune system's ability to recognize and effectively destroy cancer cells. It works on the principle that the immune system can be trained or boosted to identify cancer cells as threats, promoting a more vigorous immune response against tumors.

Agents used in biotherapy, such as monoclonal antibodies, immune checkpoint inhibitors, and cancer vaccines, play crucial roles in this enhancement. For example, monoclonal antibodies can help the immune system by marking cancer cells for destruction or by blocking the signals that cancers use to evade immune detection. Immune checkpoint inhibitors release the "brakes" on the immune system, allowing T cells to target and kill cancer cells more effectively.

By fostering a more robust immune response, biotherapy not only targets cancer cells more efficiently but also holds the potential for lasting effects, as a well-functioning immune system can continue to monitor and potentially prevent cancer recurrence after initial treatment. This interaction with the immune system exemplifies a shift from traditional cancer therapies, which often focus on direct cytotoxic effects, to approaches that utilize the body's own defense mechanisms.